Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
1h
Merck's Experimental Favezelimab/Keytruda Combo Fails In Late-Stage Colorectal Cancer Study
Merck's Phase 3 KEYFORM-007 study on the combination of favezelimab and pembrolizumab in MSS mCRC patients did not improve ...
3h
Merck fails in late-stage trial for Keytruda combo in colon cancer
Merck (MRK) stock is in focus as a Phase 3 trial for its cancer drug Keytruda in colorectal cancer patients did not meet ...
10h
Merck & Co., Inc. (MRK) Poised for 20% Gain, Analysts Say
We recently published a list of the 13 Most Undervalued Blue Chip Stocks To Buy According To Analysts. In this article, we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Would-be assassin charged
Penn suspends law professor
Campaign office damaged
School book bans surge
Woman dies in 'suicide pod’
Calls strike against 'LoL’
Texas AG appeal denied
US to waive visas for Qatar
Briefed on Iranian threats
Chemical leak in OH county
InfoWars to be auctioned off
CA new gun control laws
Study: Myopia on the rise
Storm Helene strengthens
China conducts ICBM test
Hezbollah missile intercepted
NYC schools boss retiring
Gets 2-yrs for role in fraud
Union gets more voting time
Pac-12 sues Mountain West
Johnny Cash statue unveiled
X account hacked
$375M military aid to UKR
ISR: Hezbollah leader killed
Rioter mistakenly released
‘Trump Train’ jury verdict
Executed by lethal injection
PA county ballot ruling
Feedback